LON:CLBX
Cellbxhealth PLC
ACTIONABLEMethodology gates passed
Position levels
Currenttoday
0.65p
Buy <=wait / entry
-
Trim >=take some off
-
Thesis breaknot set
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 25% | 100 / 100 | 25.0 |
| Base case | 50% | 62 / 100 | 31.0 |
| Bear case | 25% | 10 / 100 | 2.5 |
| Weighted conviction | 59 / 100 - OPPORTUNISTIC BUY | ||
Top risks
- New $65,000 statement of work signed with existing US pharmaceutical customer for processing 100 patient samples under master services agreement
- FY2026 revenue guidance raised to approximately GBP 1.8 million with FY2027 guidance of GBP 3.0 - GBP 4.0 million
- Organisational restructuring delivering more than GBP 6.6 million in annualised cash operating cost savings and 60% reduction in nine-month cash operating loss